Toxoplasma and Risk of Spontaneous Abortion: A Meta-Analysis in A Population of Iranian Women

Document Type : Systematic Review


1 Department of Parasitology, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

2 Department of Parasitology and Mycology, Faculty of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

3 Department of Disease Control, Komijan Treatment and Health Network, Arak University of Medical Science, Arak, Irann.

4 Zoonotic Diseases Research Center, Ilam University of Medical Sciences, Ilam, Iran


Toxoplasma gondii is found as an intracellular protozoan parasite in the Apicomplexa phylum that can be transmitted to the fetus and causes miscarriage, infection, and asymptomatic neonatal disease. In the present study, we characterized the seroprevalence rate of anti-Toxoplasma gondii antibodies in a population of Iranian women with a recent a spontaneous abortion. We examined our national and international databases including Irandoc, Magiran, SID, Medlib, Scopus, PubMed, and the Science Direct. The search strategy was carried out by using keywords and MeSH terms. The statistical analysis was performed by STATA 14.2. By using the random effects model and the fixed effects model the statistical analysis was performed while the heterogeneity was ≥75 and ≤50%, respectively. We used the chi-squared test and I2 index to calculate heterogeneity among studies, and for evaluating publication bias, Funnel plots and Egger tests were used. The seroprevalence positive rate of IgG among women who had experienced abortion was observed 32% [95% confidence interval (CI): 20-45%] based on the random-effects model. The seroprevalence positive rate of IgM based on the fixed-effect model and positive IgG rate based on the random-effect model was evaluated 4% (95% CI: 3-6%) and 32% (9% CI: 3-42%) among women immediately after an abortion, respectively. According to the finding of our study, toxoplasmosis can be one of the most significant causes of abortion.


  1. Blume M, Seeber F. Metabolic interactions between Toxoplasma gondii and its host. F1000Res. 2018; 7: F1000 Faculty Rev-1719.
  2. Hussain MA, Stitt V, Szabo EA, Nelan B. Toxoplasma gondii in the food supply. Pathogens. 2017; 6(2): 21.
  3. Gelaye W, Kebede T, Hailu A. High prevalence of anti-toxoplasma antibodies and absence of Toxoplasma gondii infection risk factors among pregnant women attending routine antenatal care in two Hospitals of Addis Ababa, Ethiopia. Int J Infect Dis. 2015; 34: 41-45.
  4. Molan AL, Ismail MH, Hatem SM, Al-Bayati NY. Seroprevalence of Toxoplasmosis in voluntary blood donors in Diyala Province, Iraq. Am J Life Sci. 2018; 6(4): 188-193.
  5. Lahmar I, Lachkhem A, Babba O, Slama D, Trabelsi A, Passebosc-Faure K, et al. First isolation and molecular characterization of Toxoplasma gondii strains from human congenital toxoplasmosis cases in Monastir, Tunisia. Sci Rep. 2020; 10: 1963.
  6. Norrby SR, Whitley RJ. Evaluation of new anti- infective drugs for the treatment of infection with human immunodeficiency virus. Clin Infect Dis. 1993; 17(4): 794-801.
  7. Campero LM, Schott F, Gottstein B, Deplazes P, Sidler X, Basso W. Detection of antibodies to Toxoplasma gondii in oral fluid from pigs. Int J Parasitol. 2020; 50(5): 349-355.
  8. Siala E, Bouafsoun A, Maatoug R, Souissi O, Aoun K, Bouratbine A. Toxoplasmosis mother-to-child screening: study of cases followed in the Pasteur Institute of Tunis (2007-2010). Bull Soc Pathol Exot. 2013; 106(2): 108-112.
  9. Gao X, Zhao Z, He Z, Wang T, Yang T, Chen X, et al. Toxoplasma gondii infection in pregnant women in China. Parasitology. 2012; 139(2): 139-347.
  10. Alghamdi AJ, Alabbas A, Tadla M, Agyemfra-Kumi C, Tarkowska A, Furmaga-Jabłońska W. Is congenital Toxoplasmosis still an important clinical problem? J Pre-Clin Clin Res. 2017; 11(2): 167-170.
  11. Fisch D, Clough B, Frickel EM. Human immunity to Toxoplasma gondii. PLoS Pathog. 2019; 15(12): e1008097.
  12. Parlog A, Schlüter D, Dunay IR. Toxoplasma gondii-induced neuronal alterations. Parasite Immunol. 2015; 37(3): 159-170.
  13. Chaechi Nosrati MR, Shemshadi B, Shayan P, Ranjbar Bahadory Sh, Eslami A. Serological determination of Toxoplasma gondii among sheep (ovis aries) in Guilan Province, Iran. Arch Razi Inst. 2020; 75(4): 463-471.
  14. Rozental AJ, Partnow AB, Shomper JL, Schultz RM. What is your neurologic diagnosis? J Am Vet Med. 2020; 256(7): 771-774.
  15. Lo Piccolo F, Busch K, Palić J, Geisen V, Hartmann K, Unterer S. Toxoplasma gondii- associated cholecystitis in a cat receiving immunosuppressive treatment. Tierarztl Prax Ausg K Kleintiere Heimtiere. 2019; 47(6): 453-457.
  16. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009; 6(7): e1000097.
  17. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010; 25(9): 603-605.
  18. Rasti S, Ghasemi FS, Abdoli A, Piroozmand A, Mousavi SGA, Fakhrie-Kashan Z. ToRCH "co-infections" are associated with increased risk of abortion in pregnant women. Congenit Anom. 2016; 56(2): 73-78.
  19. Gharavi MJ. Seroepidemiological survey of Toxoplasmosis in pregnant women in Tehran. Hakim Res J. 2002; 5(2): 91-98.
  20. Aali BS, Harandi F, Nazari E, Salari Z. Comparison of Toxoplasma gondii IgGand IgM seropositivity between women with spontaneous abortions and ongoing pregnancies. Iran J Obstet Gynecol Infertil. 2011; 14(1): 1-6.
  21. Amin A, Mazloomzadeh S, Haniloo A, Mohammadian F, Fazaeli A. Evaluation of anti- toxoplasma IgG, IgM, and IgA in mothers with spontaneous abortion in Zanjan, Northwest Iran. Korean J Parasitol. 2012; 50(4): 371-374.
  22. Eslamirad Z, Mosayebi M, Hajihossein R. Molecular testing for toxoplasma diagnosis in aborted fetuses-Taleghani maternity hospital-Arak-Iran. Res Mol Med. 2014; 2(3): 41-44.
  23. Ghasemi FS, Rasti S, Piroozmand A, Bandehpour M, Kazemi B, Mousavi SGA, et al. Toxoplasmosis-associated abortion and stillbirth in Tehran, Iran. J Matern-Fetal Neonatal Med. 2016; 29(2): 248-251.
  24. Matin S, Shahbazi G, Namin ST, Moradpour R, Feizi F, Piri-dogahe H. Comparison of placenta PCR and maternal serology of aborted women for detection of Toxoplasma gondii in Ardabil, Iran. Korean J Parasitol. 2017; 55(6): 607-611.
  25. Kheirandish F, Ezatpour B, Fallahi S, Tarahi MJ, Hosseini P, Rouzbahani AK, et al. Toxoplasma serology status and risk of miscarriage, a case-control study among women with a history of spontaneous abortion. Int J Fertil Steril. 2019; 13(3): 184-189.
  26. Arefkhah N, Pourabbas B, Asgari Q, Moshfe A, Mikaeili F, Nikbakht G, et al. Molecular genotyping and serological evaluation of Toxoplasma gondii in mothers and their spontaneous aborted fetuses in Southwest of Iran. Comp Immunol Microbiol Infect Dis. 2019; 66: 101342.
  27. Light RJ, Pillemer DB. Summing up: the science of reviewing research. Cambridge: Harvard University Press; 1984.
  28. Charlier C, Lecuit M. Maternal-fetal infections: why do they matter? Virulence. 2020; 11(1): 398-399.
  29. Mohajab AH, Alshehri HZ, Shati RO, Alshehri AA, Alafghani MA, Alasmari A, et al. Anti-toxoplasma antibody prevalence and cost-effectiveness in pregnant women at the king abdulaziz university hospital, Jeddah, Saudi Arabia. Cureus. 2020; 12(1): e6675.
  30. Rostami A, Riahi SM, Gamble HR, Fakhri Y, Shiadeh MN, Danesh M, et al. Global prevalence of latent Toxoplasmosis in pregnant women: a systematic review and meta-analysis. Clin Microbiol Infect. 2020; 26(6): 673-683.
  31. Nayeri T, Sarvi S, Moosazadeh M, Amouei A, Hosseininejad Z, Daryani A. The global seroprevalence of anti-Toxoplasma gondii antibodies in women who had spontaneous abortion: a systematic review and meta-analysis. PLoS Negl Trop Dis. 2020; 14(3): e0008103.
  32. Artigas RS, Maggi MA, Campi YC, Peña EB. Some epidemiological variables associated to toxoplasmosis in women of childbearing age from Riobamba. Rev Cuba de Investig Biomed. 2020; 39(1): 1-16.
  33. Moura FLd, Amendoeira MRR, Bastos OMP, Mattos DPBGd, Fonseca ABM, Nicolau JL, et al. Prevalence and risk factors for Toxoplasma gondii infection among pregnant and postpartum women attended at public healthcare facilities in the city of Niterói, State of Rio de Janeiro, Brazil. Rev Soc Bras Med Trop. 2013; 46(2): 200-207.
  34. Gebremedhin EZ, Abebe AH, Tessema TS, Tullu KD, Medhin G, Vitale M, et al. Seroepidemiology of Toxoplasma gondiiinfection in women of child-bearing age in central Ethiopia. BMC Infect Dis. 2013; 13: 101.
  35. Iddawela D, Vithana SMP, Ratnayake C. Seroprevalence of toxoplasmosis and risk factors of Toxoplasma gondii infection among pregnant women in Sri Lanka: a cross sectional study. BMC Public Health. 2017; 17(1): 930.
  36. Elfadaly H, Hassanan N, Shaapan R, Hassanain M, Barakat A, Abdelrahman K. Molecular detection and genotyping of Toxoplasma gondii from Egyptian isolates. Asian J Epidemiol. 2017; 10(1): 37-44.
  37. Alghamdi J, Elamin MH, Alhabib S. Prevalence and genotyping of Toxoplasma gondii among Saudi pregnant women in Saudi Arabia. Saudi Pharm J. 2016; 24(6): 645-651.
  38. Nijem KI, Al-Amleh S. Seroprevalence and associated risk factors of Toxoplasmosis among pregnant women in Hebron district, Palestine. East Mediterr Health J. 2009; 15(5): 1278-1284.
  39. Diaz-Suárez O, Estevez J. Seroepidemiology of toxoplasmosis in women of childbearing age from a marginal community of Maracaibo, Venezuela. Rev Inst Med trop S Paulo. 2009; 51(1): 13-17.
  40. Decavalas G, Papapetropoulou M, Giannoulaki E, Tzigounis V, Kondakis X. Prevalence of Toxoplasma gondii antibodies in gravidas and recently aborted women and study of risk factors. Eur J Epidemiol. 1990; 6(2): 223-226.
  41. Sahwi SY, Zaki MS, Haiba NY, Elsaid OK, Anwar MY, AbdRabbo SA. Toxoplasmosis as a cause of repeated abortion. J Obstet Gynaecol (Tokyo 1995). 1995; 21(2): 145-148.